author-photo

N. Dikopoulos

University of Ulm

88

Papers

646

Citations

Citation Trend

Filter By

Papers (56) Sort By

Journal Conference Others

Prevalence of resistance-associated substitutions and retreatment of patients failing a glecaprevir/pibrentasvir regimen.

2020 Journal of Antimicrobial Chemotherapy
Show All
- Source
- Cite
- Save
Citations (8)
Baseline patient characteristics of the German multicentric prospective real-world NAFLD cohort: The Fatty Liver Assessment in Germany (FLAG) study

2019 Zeitschrift Fur Gastroenterologie
Show All
- Source
- Cite
- Save
Citations (1)
Improving the quality and acceptance of colonoscopy preparation by reinforced patient education with short message service: results from a randomized, multicenter study (PERICLES-II)

2019 Gastrointestinal Endoscopy
Show All
- Source
- Cite
- Save
Citations (33)
Genetic Biopsy for Prediction of Surveillance Intervals after Endoscopic Resection of Colonic Polyps: Results of the GENESIS Study

2018 United European gastroenterology journal
Show All
- Source
- Cite
- Save
Citations (5)
Verbesserung der Koloskopievorbereitung durch eine automatisierte Patientenbegleitung per SMS; Ergebnisse der PERICLES-II-Studie

2017 Viszeralmedizin
Show All
- Source
- Cite
- Save
Citations (0)
Direkt antivirale Agentien (DAA) in der Therapie der chronischen Hepatitis C – „real-life“ Daten eines akademischen Zentrums und zwei Spezialpraxen

2017 Viszeralmedizin
Show All
- Source
- Cite
- Save
Citations (0)
Vitamin D Levels Vary during Antiviral Treatment but Are Unable to Predict Treatment Outcome in HCV Genotype 1 Infected Patients

2014 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (15)
Leukocytes decline > 2500/µl during Peginterferon Alfa-2B (PEG-2B)/Ribavirin (RBV) treatment predicts favorable SVR rates in difficult-to-treat patients with HCV Genotype 1 (G1) infection in real-life

2013 Zeitschrift Fur Gastroenterologie
Show All
- Source
- Cite
- Save
Citations (0)
912 LEUKOCYTE DECLINE PREDICTS SUSTAINED VIROLOGIC RESPONSE IN PATIENTS UNDERGOING PEGINTERFERON alfa-2b/RIBAVIRIN TREATMENT OF CHRONIC HCV GENOTYPE 1 INFECTION

2013 Journal of Hepatology
Show All
- Source
- Cite
- Save
Citations (0)
Age- and gender-related differences in SVR and relapse following treatment of HCV genotype 3 (G3) infection with Peginterferon alfa-2b (peg2b)/Ribavirin (RBV) in real-life

2013 Zeitschrift Fur Gastroenterologie
Show All
- Source
- Cite
- Save
Citations (0)